However, inhibition of VEGF by anti-VEGF antibodies resulted in systemic adverse effects such as thromboembolic events, hemorrhage, gastrointestinal perforation, hypertension, and nephrotic syndrome [15]. This evidence concerns the gene VEGFA and hypertensive disorder.